Proud father, husband, rock and ice climber, and clinical scientist and professor passionate about valvular heart disease and cardiovascular imaging

Québec, Canada
Joined February 2017
The Heart Valve Society and Its Journal Finally Meet – The Future Is Bright. In the first inaugural issue of the #JournaloftheHeartValveSociety (journals.sagepub.com/toc/HVS…), Dr @IHamamsy, the president of the #HVS highlights the rising global burden of heart valve disease and the need for innovative, and collaborative solutions. The Society aims to advance cutting-edge research and support future leaders in the field. Their upcoming 2025 meeting in Cairo underscores their commitment to global partnerships and improving care worldwide. Read more here👇 journals.sagepub.com/doi/ful…
2
7
600
✨Just published in the first issue of the #JHVS: 3-year results of the AVIATOR REGISTRY🫀 including 2,206 patients with aortic valve regurgitation who underwent aortic valve intervention. Surgical repair was associated with better survival than valve replacement. AR ≥ grade 2 at discharge was more frequent in repair vs. replacement and was a strong predictor for reintervention. journals.sagepub.com/doi/ful… Insightful editorial by Alessandro Della Corte: journals.sagepub.com/doi/ful…
2
3
384
Delve into the intricate dynamics of the extracellular matrix in the aortic valve, particularly on its role in health and disease such as calcific aortic stenosis (CAS), innovative biomimetic platforms that mimic CAS fibrosis, and insights for developing therapeutic strategies. Read more here👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety #KristynMasters
2
318
Just published in the first issue of #JHVS: Women with small aortic annulus are less likely to experience prosthesis-patient mismatch (PPM) after TAVR compared to SAVR. Read more here👇 journals.sagepub.com/doi/ful… Link to the editorial👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety @JessicaForcillo
4
2
355
Approximately 9% of the patients with severe AS also had PAD. Notably, these patients faced a significantly higher risk of mortality, with a 1.6-fold increase compared to those without PAD. The presence of both PAD and CAD exacerbated the risk, leading to a 1.92-fold increase in mortality. Read more here👇 journals.sagepub.com/doi/ful… To read the associated and insightful editorial link below👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
3
1
305
Just published in the first issue of the #JHVS: Cardiovascular magnetic resonance as a non-invasive tool to assess myocardial fibrosis in AS. This elegant review underscores the prognostic value of these imaging markers such as late gadolinium enhancement (LGE) and T1-mapping and discusses potential future directions, such as novel biomarkers and the development of sex-specific data to refine risk stratification and intervention timing. Read more here👇 journals.sagepub.com/doi/ful…
3
2
267
Just published in the first issue of JHVS: Focus on the complex interplay between cardiac amyloidosis and aortic stenosis. Importance of heightened clinical awareness, early diagnosis through advanced imaging, and tailored therapeutic strategies to improve patient outcomes. Read more below👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety @ftournoux #DaniaMohty @ChetritMichael
3
1
270
Just published in the first issue of #JHVS: Intersection of AS and chronic kidney disease (CKD): a call to action for clinicians to adopt a comprehensive, patient-centered approach in managing AS in CKD, advocating for guidelines that address this complex clinical interplay. Read more here👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
3
2
327
The role of multimodality imaging in assessing AS and the challenges and advancements in diagnosing AS. The review emphasizes the importance of less flow-dependent modalities in evaluating AS severity and underscores the evolving landscape of AS assessment, highlighting the necessity of integrating multiple imaging approaches to enhance diagnostic accuracy and patient outcomes. Read more here👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
3
2
275
Just published in the first issue of #JHVS: The Ross procedure in adults, a surgical technique that has gained renewed interest in recent years. This review highlights the evolution of surgical techniques to enhance the durability of the Ross procedure, addressing potential complications such as autograft dilatation and the need for reintervention, and the importance of surgical expertise and patient-specific tailoring of the procedure to optimize outcomes. Read more below👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety @IHamamsy
5
2
256
The Aortic Valve Research Network Investigators presents the Heart Valve Society Aortic Valve Database, which is a pivotal resource in advancing our understanding and treatment of aortic valve disease. The #HVS Aortic Valve Database is a comprehensive, multicenter platform established to harmonize long-term data on patient outcomes following aortic valve interventions, and provides a critical tool in the ongoing effort to standardize care and improve outcomes for patients with aortic valve disease. Read more here👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
4
2
191
Challenging the recently introduced concept of extra-valvular cardiac damage staging in #HVD by introducing the importance of considering the entire spectrum of cardiac damage when deciding on interventions, as these procedures, although often improving symptoms, may not always lead to long-term improvements in cardiac health. Readn more here 👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
5
4
251
🥊Just published in the first issue of #JHVS: Which is the best modality to assess bioprosthetic valve hemodynamic function and adjudicate valve dysfunction following transcatheter aortic valve replacement: Doppler echocardiography or invasive assessment by cardiac catheterization? In the pro-side article, Drs Rebecca T. Hahn and @TernacleJ explore the efficacy and necessity of using Doppler-echocardiography over invasive catheterization to diagnose bioprosthetic valve dysfunction (BVD) following transcatheter aortic valve replacement (TAVR). In the con-side, Drs Houman Khalili and @amrabbasmd, argues that while echocardiography is commonly employed for evaluating bioprosthetic valves, it often presents limitations, particularly when it comes to isolated high gradients. Read more here 👇 journals.sagepub.com/doi/ful… journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
6
1
10
2,038
Just published in the first issue of #JHVS: Cahalane et al. present the mission of the recently launched young investigator board of the Heart Valve Society, an initiative that not only provides a platform for networking and collaboration but also offers resources for career advancement and interdisciplinary engagement. Read more below 👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety @RachelCahalane
4
3
219
Just published in this first issue of the #JHVS: The first ICHOM standards for the reporting of patient-centered outcomes in heart valve disease. The ICHOM Set of Patient-Centered Outcome Measures for Heart Valve Disease results from hard work by a group of leading healthcare providers, researchers, and patient representatives. It represents the outcomes that matter most to people (≥18 years old) with #HVD. Read more here 👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety @EmmanuelLansac @ICHOM_ORG
4
3
216
Just published in the first issue of #JHVS: In-memoriam🕊️article to underline the outstanding career and contribution of Pr Alain Cribier, who passed away earlier this year. Pr Alain Cribier was a pioneer and a giant in the advancement of the treatment of #HVD. He and his team at @CHURouen in France have been the first to perform aortic balloon valvuloplasty and transcatheter aortic valve replacement, which have transformed the therapeutic management of aortic valve disease. Read the article here 👇 journals.sagepub.com/doi/ful… #JournaloftheHeartValveSociety
4
4
323
Dear followers I will not post anymore on X. I encourage you to follow me on BlueSky or LinkedIn. Thank you for your support. Chers followers, à partir d’aujourd’hui je n’utiliserai plus la plateforme X. Je vous encourage à me suivre sur BlueSky et LinkedIn. Merci.
3
6
341
Very proud and honored to be in 2024 for the seventh consecutive year among the most influential scientists in clinical medicine. I am so grateful to my wonderful team @IUCPQ
3
3
43
1,234
TAVR UNLOAD just presented at TCT. First RCT in moderate AS and HFrEF. The trial did not meet the primary endpoint at last FU but early TAVR was superior to clinical surveillance at 1 year.
3
16
3
58
10,668